Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[The ALK (anaplastic lymphoma kinase) RTK was originally identified as a member of the insulin receptor subfamily of RTKs that acquires transforming capability when truncated and fused to NPM (nucleophosmin) in the t(2;5) chromosomal rearrangement associated with ALCL (anaplastic large cell lymphoma).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[The ALK (anaplastic lymphoma kinase) RTK was originally identified as a member of the insulin receptor subfamily of RTKs that acquires transforming capability when truncated and fused to NPM (nucleophosmin) in the t(2;5) chromosomal rearrangement associated with ALCL (anaplastic large cell lymphoma).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP325293.RAcgTmFC3UfJpckty6gtq1JT2DKvo_k0dSVcOQaIDFYSk130_assertion description "[The ALK (anaplastic lymphoma kinase) RTK was originally identified as a member of the insulin receptor subfamily of RTKs that acquires transforming capability when truncated and fused to NPM (nucleophosmin) in the t(2;5) chromosomal rearrangement associated with ALCL (anaplastic large cell lymphoma).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP325293.RAcgTmFC3UfJpckty6gtq1JT2DKvo_k0dSVcOQaIDFYSk130_provenance.
• assertion description "[The ALK (anaplastic lymphoma kinase) RTK was originally identified as a member of the insulin receptor subfamily of RTKs that acquires transforming capability when truncated and fused to NPM (nucleophosmin) in the t(2;5) chromosomal rearrangement associated with ALCL (anaplastic large cell lymphoma).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP731522.RASWahyoSx5uaBPUYw-icY8Jq4O_FJM0ovtVR-zvp1S8E130_assertion description "[The ALK (anaplastic lymphoma kinase) RTK was originally identified as a member of the insulin receptor subfamily of RTKs that acquires transforming capability when truncated and fused to NPM (nucleophosmin) in the t(2;5) chromosomal rearrangement associated with ALCL (anaplastic large cell lymphoma).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP731522.RASWahyoSx5uaBPUYw-icY8Jq4O_FJM0ovtVR-zvp1S8E130_provenance.
• NP513765.RAcfe_iWtIErlPiLaig7PvJwwrKvo3pj5-3QlRiz87mZM130_assertion description "[The ALK (anaplastic lymphoma kinase) RTK was originally identified as a member of the insulin receptor subfamily of RTKs that acquires transforming capability when truncated and fused to NPM (nucleophosmin) in the t(2;5) chromosomal rearrangement associated with ALCL (anaplastic large cell lymphoma).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP513765.RAcfe_iWtIErlPiLaig7PvJwwrKvo3pj5-3QlRiz87mZM130_provenance.
• assertion description "[The ALK (anaplastic lymphoma kinase) RTK was originally identified as a member of the insulin receptor subfamily of RTKs that acquires transforming capability when truncated and fused to NPM (nucleophosmin) in the t(2;5) chromosomal rearrangement associated with ALCL (anaplastic large cell lymphoma).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The ALK (anaplastic lymphoma kinase) RTK was originally identified as a member of the insulin receptor subfamily of RTKs that acquires transforming capability when truncated and fused to NPM (nucleophosmin) in the t(2;5) chromosomal rearrangement associated with ALCL (anaplastic large cell lymphoma).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The ALK (anaplastic lymphoma kinase) RTK was originally identified as a member of the insulin receptor subfamily of RTKs that acquires transforming capability when truncated and fused to NPM (nucleophosmin) in the t(2;5) chromosomal rearrangement associated with ALCL (anaplastic large cell lymphoma).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The ALK (anaplastic lymphoma kinase) RTK was originally identified as a member of the insulin receptor subfamily of RTKs that acquires transforming capability when truncated and fused to NPM (nucleophosmin) in the t(2;5) chromosomal rearrangement associated with ALCL (anaplastic large cell lymphoma).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP740374.RAC-v90CXIgLIoi4Q14rVbsS1FGTAyONoHZegbFYd49rI130_assertion description "[The ALK (anaplastic lymphoma kinase) RTK was originally identified as a member of the insulin receptor subfamily of RTKs that acquires transforming capability when truncated and fused to NPM (nucleophosmin) in the t(2;5) chromosomal rearrangement associated with ALCL (anaplastic large cell lymphoma).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP740374.RAC-v90CXIgLIoi4Q14rVbsS1FGTAyONoHZegbFYd49rI130_provenance.
• NP597757.RArFwyTPClcRQpWDLYYACrLwTysH0lsgtT6rSMWTUwHW0130_assertion description "[The ALK (anaplastic lymphoma kinase) RTK was originally identified as a member of the insulin receptor subfamily of RTKs that acquires transforming capability when truncated and fused to NPM (nucleophosmin) in the t(2;5) chromosomal rearrangement associated with ALCL (anaplastic large cell lymphoma).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP597757.RArFwyTPClcRQpWDLYYACrLwTysH0lsgtT6rSMWTUwHW0130_provenance.
• NP740378.RAbsBHQx-fgzmxj8Us4AsxXNi1sL4WE_a7xrunm0UZKRo130_assertion description "[The ALK (anaplastic lymphoma kinase) RTK was originally identified as a member of the insulin receptor subfamily of RTKs that acquires transforming capability when truncated and fused to NPM (nucleophosmin) in the t(2;5) chromosomal rearrangement associated with ALCL (anaplastic large cell lymphoma).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP740378.RAbsBHQx-fgzmxj8Us4AsxXNi1sL4WE_a7xrunm0UZKRo130_provenance.
• NP513899.RAgPypD96yVpiRVHiGCtDguNUSwpFtScKOw_6ZIZKy-6Q130_assertion description "[The ALK (anaplastic lymphoma kinase) RTK was originally identified as a member of the insulin receptor subfamily of RTKs that acquires transforming capability when truncated and fused to NPM (nucleophosmin) in the t(2;5) chromosomal rearrangement associated with ALCL (anaplastic large cell lymphoma).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP513899.RAgPypD96yVpiRVHiGCtDguNUSwpFtScKOw_6ZIZKy-6Q130_provenance.
• NP922959.RAM1OuyEKNUo2gVtfWe7UXG5GNU7SuPyDmOnmgRUaZCQg130_assertion description "[The ALK (anaplastic lymphoma kinase) RTK was originally identified as a member of the insulin receptor subfamily of RTKs that acquires transforming capability when truncated and fused to NPM (nucleophosmin) in the t(2;5) chromosomal rearrangement associated with ALCL (anaplastic large cell lymphoma).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP922959.RAM1OuyEKNUo2gVtfWe7UXG5GNU7SuPyDmOnmgRUaZCQg130_provenance.
• NP740372.RAhtFMOCgugwx9DbYLxeilwywhOANRqOA6Sf8-LcBpvLc130_assertion description "[The ALK (anaplastic lymphoma kinase) RTK was originally identified as a member of the insulin receptor subfamily of RTKs that acquires transforming capability when truncated and fused to NPM (nucleophosmin) in the t(2;5) chromosomal rearrangement associated with ALCL (anaplastic large cell lymphoma).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP740372.RAhtFMOCgugwx9DbYLxeilwywhOANRqOA6Sf8-LcBpvLc130_provenance.
• NP235746.RAxCsUev1QQpaas6v6arpgeUml1lNEInY_zoFXOLUaSxc130_assertion description "[The ALK (anaplastic lymphoma kinase) RTK was originally identified as a member of the insulin receptor subfamily of RTKs that acquires transforming capability when truncated and fused to NPM (nucleophosmin) in the t(2;5) chromosomal rearrangement associated with ALCL (anaplastic large cell lymphoma).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP235746.RAxCsUev1QQpaas6v6arpgeUml1lNEInY_zoFXOLUaSxc130_provenance.
• NP513920.RA-e0dcgUVC6lKkNEjfZqf-Hsn4pM5zXQrjwWK0PWwCs8130_assertion description "[The ALK (anaplastic lymphoma kinase) RTK was originally identified as a member of the insulin receptor subfamily of RTKs that acquires transforming capability when truncated and fused to NPM (nucleophosmin) in the t(2;5) chromosomal rearrangement associated with ALCL (anaplastic large cell lymphoma).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP513920.RA-e0dcgUVC6lKkNEjfZqf-Hsn4pM5zXQrjwWK0PWwCs8130_provenance.
• NP597779.RA2IH41mfFFeZv3lRKTRv9ho_7H2MKDJqpvYVzhdAr3v4130_assertion description "[The ALK (anaplastic lymphoma kinase) RTK was originally identified as a member of the insulin receptor subfamily of RTKs that acquires transforming capability when truncated and fused to NPM (nucleophosmin) in the t(2;5) chromosomal rearrangement associated with ALCL (anaplastic large cell lymphoma).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP597779.RA2IH41mfFFeZv3lRKTRv9ho_7H2MKDJqpvYVzhdAr3v4130_provenance.
• NP740373.RAOCtm89TF4dpz7HY0nxYZnksbu2lzSGy7IhOwrvP5QOc130_assertion description "[The ALK (anaplastic lymphoma kinase) RTK was originally identified as a member of the insulin receptor subfamily of RTKs that acquires transforming capability when truncated and fused to NPM (nucleophosmin) in the t(2;5) chromosomal rearrangement associated with ALCL (anaplastic large cell lymphoma).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP740373.RAOCtm89TF4dpz7HY0nxYZnksbu2lzSGy7IhOwrvP5QOc130_provenance.
• NP740377.RAIy9gZBpJwiH1jES4duAltq3cqKQuRtyl_OWHZM3X0qY130_assertion description "[The ALK (anaplastic lymphoma kinase) RTK was originally identified as a member of the insulin receptor subfamily of RTKs that acquires transforming capability when truncated and fused to NPM (nucleophosmin) in the t(2;5) chromosomal rearrangement associated with ALCL (anaplastic large cell lymphoma).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP740377.RAIy9gZBpJwiH1jES4duAltq3cqKQuRtyl_OWHZM3X0qY130_provenance.
• NP740381.RAPpL9ldiUyLC9k_pyJ_MsD6HhP2QOP-Eg1lT4XKJf-7U130_assertion description "[The ALK (anaplastic lymphoma kinase) RTK was originally identified as a member of the insulin receptor subfamily of RTKs that acquires transforming capability when truncated and fused to NPM (nucleophosmin) in the t(2;5) chromosomal rearrangement associated with ALCL (anaplastic large cell lymphoma).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP740381.RAPpL9ldiUyLC9k_pyJ_MsD6HhP2QOP-Eg1lT4XKJf-7U130_provenance.
• NP740375.RA5YziuehZKbYhtPq7AESs9znTrmvt6zNM6KL54vW_WAo130_assertion description "[The ALK (anaplastic lymphoma kinase) RTK was originally identified as a member of the insulin receptor subfamily of RTKs that acquires transforming capability when truncated and fused to NPM (nucleophosmin) in the t(2;5) chromosomal rearrangement associated with ALCL (anaplastic large cell lymphoma).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP740375.RA5YziuehZKbYhtPq7AESs9znTrmvt6zNM6KL54vW_WAo130_provenance.
• NP740379.RA4teBhi9WwCo0gHFfioTXR2SKMiHiCqb1eVoWne_zcbM130_assertion description "[The ALK (anaplastic lymphoma kinase) RTK was originally identified as a member of the insulin receptor subfamily of RTKs that acquires transforming capability when truncated and fused to NPM (nucleophosmin) in the t(2;5) chromosomal rearrangement associated with ALCL (anaplastic large cell lymphoma).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP740379.RA4teBhi9WwCo0gHFfioTXR2SKMiHiCqb1eVoWne_zcbM130_provenance.
• NP740380.RAzlbPdYFzakPzQZCfXNuWntj_v2gJPXSIDO1Uyb_oaZo130_assertion description "[The ALK (anaplastic lymphoma kinase) RTK was originally identified as a member of the insulin receptor subfamily of RTKs that acquires transforming capability when truncated and fused to NPM (nucleophosmin) in the t(2;5) chromosomal rearrangement associated with ALCL (anaplastic large cell lymphoma).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP740380.RAzlbPdYFzakPzQZCfXNuWntj_v2gJPXSIDO1Uyb_oaZo130_provenance.